Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of ORIC Pharmaceuticals's ORIC-944?
ORIC-944 is a small molecule commercialized by ORIC Pharmaceuticals, with a leading Phase I program in Metastatic Castration-Resistant Prostate Cancer...